Neuralink Corporation sits at an unusual intersection in the pre-IPO secondary market. It is a high-visibility name — the company's brain-computer interface work generates significant media attention — but it operates with a relatively small capitalization base and tight control over its shareholder register. That combination produces a secondary market characterized by wide bid-ask spreads, sporadic supply, and meaningful structural choices for buyers.
The most consequential of those choices is how you hold the exposure: through an SPV (special purpose vehicle) or via a direct share transfer. For many issuers, this is largely a cost and convenience question. For Neuralink, it is also a question about what rights you actually hold, how quickly you can exit, and how responsive the company is likely to be at the time of transfer.
Why Neuralink's structure creates secondary complexity
Neuralink was founded in 2016 and has raised capital across a relatively small number of rounds compared to peers of similar public profile. The company does not publish detailed cap table information, and its investor base includes both institutional names and early employees who received equity at early-stage prices. That combination — limited public data, small shareholder pool, high public interest — creates the conditions for information asymmetry in the secondary market.
Buyers arriving at the secondary market are typically working from a combination of 409A valuation signals (which represent the IRS-aligned fair market value of common shares, not a market clearing price), implied valuations from reported primary funding rounds, and pricing data from marketplace transactions. None of these sources is fully transparent, and they frequently diverge.
SPV structure: what you gain and what you give up
When you purchase a membership interest in an SPV that holds Neuralink shares, you are not a shareholder of Neuralink. You are a limited partner (or member) of a fund-like vehicle. The SPV's general partner or manager sits on the Neuralink cap table; you hold an interest in the SPV.
This structure has genuine advantages. The company only needs to approve one transfer — from the original shareholder to the SPV — rather than tracking a new direct shareholder every time an interest changes hands within the vehicle. That makes the initial transfer cleaner and, in some cases, reduces ROFR friction. It also allows multiple buyers to pool into a single vehicle, which can lower the effective entry size per investor.
- Simpler cap table impact: the company adds one name (the SPV), not multiple individual investors.
- Lower minimum per investor when the SPV is pooled across participants.
- SPV documents handle corporate actions — dividends, secondary tender offers, ROFR notices — on your behalf.
- Exit requires selling your SPV interest, not the underlying shares, which may be faster depending on the SPV's transfer restrictions.
The trade-offs are equally real. You have no direct relationship with Neuralink as an SPV investor. Information rights — if they were negotiated at all — belong to the SPV manager, not to you. If the SPV manager receives a shareholder update or a tender offer notice, they are obligated to pass it to you, but the timing and completeness of that communication depends on the quality of the manager. You should review the SPV's operating agreement carefully before committing capital.
SPV fees also compound over a hold period. A typical structure charges a management fee (often 1–2% per year on invested capital) and carry (commonly 10–20% of profits above a hurdle). On a five-year hold, that fee drag can meaningfully reduce your net return even if the underlying shares perform well. The Limen Markets explainer on SPV fees and carry at /resources/spv-fees-carry-explained walks through the math in detail.
Direct transfer: what it requires and when it is worth the friction
A direct share transfer in Neuralink means you become a named shareholder on the company's cap table. This requires the company's consent and, in most cases, a ROFR waiver from existing shareholders or the company itself. For a company with tight cap table control, that process can take longer than the secondary market average and may be declined for buyers who do not meet the company's internal criteria for acceptable shareholders.
If the transfer is approved, the buyer gains a cleaner legal claim to the shares. You hold common stock (or units, depending on the company's structure) directly. Any information rights attached to those shares — which for common shareholders at a private company are typically minimal — belong to you. You also have direct standing if the company initiates a tender offer or a drag-along transaction.
- No ongoing management fee or carry — your cost basis is fixed at purchase price plus transaction costs.
- Direct shareholder standing in the event of a merger, tender offer, or drag-along.
- Cleaner exit if the company goes public — your shares convert directly, without an SPV liquidation step.
- Simpler tax reporting in most cases: your cost basis is clear, your holding period starts at transfer, and you receive no K-1 from a fund vehicle.
The friction is real. Direct transfers require more company engagement, longer timelines in some cases, and a higher minimum — most direct secondary transactions in names like Neuralink are not available below $100,000 to $250,000 in notional value because sellers and the company prefer fewer, larger transfers to minimize cap table complexity.
What drives the bid-ask spread in Neuralink secondary
Neuralink's secondary market spread — the gap between what buyers will pay and what sellers will accept — tends to be wider than for more liquid names like Stripe or Databricks. Several factors drive this.
First, supply is thin. The company has fewer shareholders than a business that has raised ten or more rounds, and those shareholders may face contractual restrictions on transfer. When supply is scarce, the few sellers who are willing to transact can hold out for a premium — or may not transact at all if market conditions are unclear.
Second, the information environment is opaque. Without regular press coverage of primary rounds or secondary tender programs, buyers and sellers are pricing off incomplete signals. Buyers discount for uncertainty; sellers may anchor to the last known round price even if time has passed and conditions have changed.
Third, the technology risk profile is distinctive. Unlike a fintech or enterprise software business where revenue metrics provide some pricing anchor, Neuralink's value is concentrated in its regulatory pathway, clinical trial results, and long-term commercial potential. That makes valuation more contested and bid-ask spreads wider by nature.
Decision framework: SPV or direct for Neuralink
The right structure depends on your capital size, your hold horizon, and how much operational simplicity matters to you. Use this framework as a starting point.
Before you commit capital
Review the SPV operating agreement or direct transfer agreement in full before signing. Confirm the ROFR timeline with the marketplace so you know the expected settlement window. Model your net return under multiple exit scenarios — including an exit price below your entry — accounting for carry and fees if you are buying through an SPV.
The Limen Markets marketplace shows current Neuralink supply with confirmed seller-side availability, templated SPV documents, and ROFR processing handled in parallel with execution. If you are ready to review live indications, visit /marketplace.